Search research articles
Contact Us
Filters
Showing results (151-160 of 178) with videos related to
Page
of 18
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 23, 2012
Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy
T E Twaroch, M Focke, K Fleischmann, et al.
Cancer
|
January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease
M Aglietta, F Montemurro, F Fagioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 1999
Thymic transplantation across an MHC class I barrier in swine
G W Haller, N Esnaola, K Yamada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
M Tazdait, L Mezquita, J Lahmar, et al.
Transplantation
|
May 15, 2001
Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine
J L Bourget, D W Mathes, G P Nielsen, et al.
Critical Reviews in Oncology/Hematology
|
February 17, 2020
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
F Passiglia, L Bertolaccini, M Del Re, et al.
Nature Communications
|
October 25, 2022
Common evolutionary origin of acoustic communication in choanate vertebrates
Gabriel Jorgewich-Cohen, Simon William Townsend, Linilson Rodrigues Padovese, et al.
Critical Reviews in Oncology/Hematology
|
January 10, 2020
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
F Passiglia, S Pilotto, F Facchinetti, et al.
Respiratory Medicine and Research
|
September 27, 2020
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy
C Lefebvre, E Martin, L E L Hendriks, et al.
Respiratory Research
|
August 27, 2016
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
U Peretti, R Ferrara, S Pilotto, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 178) with videos related to
Sort By:
Page
of 18
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 23, 2012
Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy
T E Twaroch, M Focke, K Fleischmann, et al.
Cancer
|
January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease
M Aglietta, F Montemurro, F Fagioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 1999
Thymic transplantation across an MHC class I barrier in swine
G W Haller, N Esnaola, K Yamada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
M Tazdait, L Mezquita, J Lahmar, et al.
Transplantation
|
May 15, 2001
Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine
J L Bourget, D W Mathes, G P Nielsen, et al.
Critical Reviews in Oncology/Hematology
|
February 17, 2020
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
F Passiglia, L Bertolaccini, M Del Re, et al.
Nature Communications
|
October 25, 2022
Common evolutionary origin of acoustic communication in choanate vertebrates
Gabriel Jorgewich-Cohen, Simon William Townsend, Linilson Rodrigues Padovese, et al.
Critical Reviews in Oncology/Hematology
|
January 10, 2020
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
F Passiglia, S Pilotto, F Facchinetti, et al.
Respiratory Medicine and Research
|
September 27, 2020
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy
C Lefebvre, E Martin, L E L Hendriks, et al.
Respiratory Research
|
August 27, 2016
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
U Peretti, R Ferrara, S Pilotto, et al.
Page
of 18